M Miler1, N Nikolac2, D Segulja3, S Kackov Maslac4, I Celap2, K Altabas5, S Sefer5, A M Simundic6. 1. University Department of Chemistry, Sestre Milosrdnice Medical School University Hospital, Zagreb, Croatia. marijana.miler@gmail.com. 2. University Department of Chemistry, Sestre Milosrdnice Medical School University Hospital, Zagreb, Croatia. 3. Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia. 4. Medical Biochemistry Laboratory, Policlinic Bonifarm, Zagreb, Croatia. 5. Department of Nephrology and Dialysis, Medical School University Hospital Sestre Milosrdnice, Zagreb, Croatia. 6. Department of Medical Laboratory Diagnostics, University Hospital "Sveti Duh", Zagreb, Croatia.
Abstract
PURPOSE: Low-grade chronic inflammation is present in patients on peritoneal dialysis (PD) and in metabolic syndrome (MS). Due to possible greater endothelial changes in dialyzed patients, inflammatory response and oxidative stress are probably stronger in patients on PD. The objective of the study was to investigate possible in between adipokines, inflammatory, endothelial and oxidative stress markers between MS patients and patients on PD. METHODS: Concentrations of adipokines (leptin, resistin), inflammatory markers [interleukin-6 (IL-6), soluble tumor necrosis factor alpha receptor (sTNF-R), myeloperoxidase (MPO), monocyte chemoattractant protein 1 (MCP-1)] and endothelial markers [soluble intracellular adhesion molecule-1 (sICAM-1), soluble CD40 ligand (sCD40L)] were determined in 55 MS patients and 18 patients on PD, with flow cytometry, and visfatin concentration was measured with ELISA. Routine biochemistry parameters were measured on Beckman Coulter AU2700 analyzer. RESULTS: Patients on PD have significantly higher concentration of: CRP [6.5 (3.7-12.1) versus 2.6 (1.3-4.0) mg/L, P < 0.001], IL-6 [13.83 (8.48-31.31) versus 2.05 (0.67-4.11) pg/mL, P < 0.001], MCP-1 [2172.28 (1563.84-2922.77) versus 1353.58 (1166.33-1961.70) pg/mL, P = 0.023], sTNF-R [18.25 (12.81-25.22) versus 1.23 (0.89-1.43) ng/mL, P < 0.001] and sICAM-1 [830.03 (599.21-967.02) versus 463.85 (315.25-751.71) ng/mL, P = 0.006] than subjects with MS. MS patients have higher concentrations of MPO [175.47 (120.15-231.67) versus 101.76 (53.55-186.06) ng/mL, P = 0.016] and visfatin [1.5 (0.9-2.3) versus 0.9 (0.6-1.6) ng/mL, P = 0.013]. CONCLUSION: In patients on PD, inflammatory reaction is higher than in patients with MS. On the contrary, patients with MS have stronger oxidative stress response and adipose tissue activity caused probably by the chronic low level of inflammation and underlying metabolic disorders.
PURPOSE: Low-grade chronic inflammation is present in patients on peritoneal dialysis (PD) and in metabolic syndrome (MS). Due to possible greater endothelial changes in dialyzed patients, inflammatory response and oxidative stress are probably stronger in patients on PD. The objective of the study was to investigate possible in between adipokines, inflammatory, endothelial and oxidative stress markers between MSpatients and patients on PD. METHODS: Concentrations of adipokines (leptin, resistin), inflammatory markers [interleukin-6 (IL-6), soluble tumor necrosis factor alpha receptor (sTNF-R), myeloperoxidase (MPO), monocyte chemoattractant protein 1 (MCP-1)] and endothelial markers [soluble intracellular adhesion molecule-1 (sICAM-1), soluble CD40 ligand (sCD40L)] were determined in 55 MSpatients and 18 patients on PD, with flow cytometry, and visfatin concentration was measured with ELISA. Routine biochemistry parameters were measured on Beckman Coulter AU2700 analyzer. RESULTS:Patients on PD have significantly higher concentration of: CRP [6.5 (3.7-12.1) versus 2.6 (1.3-4.0) mg/L, P < 0.001], IL-6 [13.83 (8.48-31.31) versus 2.05 (0.67-4.11) pg/mL, P < 0.001], MCP-1 [2172.28 (1563.84-2922.77) versus 1353.58 (1166.33-1961.70) pg/mL, P = 0.023], sTNF-R [18.25 (12.81-25.22) versus 1.23 (0.89-1.43) ng/mL, P < 0.001] and sICAM-1 [830.03 (599.21-967.02) versus 463.85 (315.25-751.71) ng/mL, P = 0.006] than subjects with MS. MSpatients have higher concentrations of MPO [175.47 (120.15-231.67) versus 101.76 (53.55-186.06) ng/mL, P = 0.016] and visfatin [1.5 (0.9-2.3) versus 0.9 (0.6-1.6) ng/mL, P = 0.013]. CONCLUSION: In patients on PD, inflammatory reaction is higher than in patients with MS. On the contrary, patients with MS have stronger oxidative stress response and adipose tissue activity caused probably by the chronic low level of inflammation and underlying metabolic disorders.
Authors: Marina Souza Silva Velloso; Alba Otoni; Adriano de Paula Sabino; Whocely Victor de Castro; Sérgio Wyton Lima Pinto; Maria Aparecida Silva Marinho; Danyelle Romana Alves Rios Journal: Clin Chim Acta Date: 2013-12-11 Impact factor: 3.786
Authors: Dorota Sikorska; Krzysztof Pawlaczyk; Magdalena Roszak; Natasza Czepulis; Andrzej Oko; Marek Karczewski; Andrzej Breborowicz; Janusz Witowski Journal: Cytokine Date: 2016-06-29 Impact factor: 3.861
Authors: Lucas José Sá da Fonseca; Valéria Nunes-Souza; Glaucevane da Silva Guedes; Glauber Schettino-Silva; Marco Antônio Mota-Gomes; Luíza Antas Rabelo Journal: Oxid Med Cell Longev Date: 2014-10-15 Impact factor: 6.543